1. Home
  2. AGYS vs DYN Comparison

AGYS vs DYN Comparison

Compare AGYS & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilysys Inc.

AGYS

Agilysys Inc.

HOLD

Current Price

$121.14

Market Cap

3.4B

Sector

Technology

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$20.05

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGYS
DYN
Founded
1963
1984
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.4B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AGYS
DYN
Price
$121.14
$20.05
Analyst Decision
Buy
Strong Buy
Analyst Count
6
17
Target Price
$142.20
$40.00
AVG Volume (30 Days)
139.7K
3.2M
Earning Date
01-20-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.86
N/A
Revenue
$299,809,000.00
N/A
Revenue This Year
$17.52
N/A
Revenue Next Year
$16.28
N/A
P/E Ratio
$141.13
N/A
Revenue Growth
17.77
N/A
52 Week Low
$63.71
$6.36
52 Week High
$145.25
$26.22

Technical Indicators

Market Signals
Indicator
AGYS
DYN
Relative Strength Index (RSI) 46.98 50.94
Support Level $118.29 $18.43
Resistance Level $124.92 $21.00
Average True Range (ATR) 3.11 1.31
MACD -0.50 0.01
Stochastic Oscillator 27.88 31.91

Price Performance

Historical Comparison
AGYS
DYN

About AGYS Agilysys Inc.

Agilysys Inc provides hospitality software delivering cloud-native SaaS and on-premise solutions for hotels, resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It derives maximum revenue from the provision of software subscription and maintenance services, followed by the provision of professional services, and the sale of products (proprietary software licenses, third-party hardware, and operating systems). Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: